Cargando…

Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations

CONTEXT: From one country to another, the pay-for-performance mechanisms differ on one significant point: the identification of target populations, that is, populations which serve as a basis for calculating the indicators. The aim of this study was to compare clinical versus medication-based identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saint-Lary, Olivier, Boisnault, Philippe, Naiditch, Michel, Szidon, Philippe, Duhot, Didier, Bourgueil, Yann, Pelletier-Fleury, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334971/
https://www.ncbi.nlm.nih.gov/pubmed/22536430
http://dx.doi.org/10.1371/journal.pone.0035721
_version_ 1782230718246551552
author Saint-Lary, Olivier
Boisnault, Philippe
Naiditch, Michel
Szidon, Philippe
Duhot, Didier
Bourgueil, Yann
Pelletier-Fleury, Nathalie
author_facet Saint-Lary, Olivier
Boisnault, Philippe
Naiditch, Michel
Szidon, Philippe
Duhot, Didier
Bourgueil, Yann
Pelletier-Fleury, Nathalie
author_sort Saint-Lary, Olivier
collection PubMed
description CONTEXT: From one country to another, the pay-for-performance mechanisms differ on one significant point: the identification of target populations, that is, populations which serve as a basis for calculating the indicators. The aim of this study was to compare clinical versus medication-based identification of populations of patients with diabetes and hypertension over the age of 50 (for men) or 60 (for women), and any consequences this may have on the calculation of P4P indicators. METHODS: A comparative, retrospective, observational study was carried out with clinical and prescription data from a panel of general practitioners (GPs), the Observatory of General Medicine (OMG) for the year 2007. Two indicators regarding the prescription for statins and aspirin in these populations were calculated. RESULTS: We analyzed data from 21.690 patients collected by 61 GPs via electronic medical files. Following the clinical-based approach, 2.278 patients were diabetic, 8,271 had hypertension and 1.539 had both against respectively 1.730, 8.511 and 1.304 following the medication-based approach (% agreement = 96%, kappa = 0.69). The main reasons for these differences were: forgetting to code the morbidities in the clinical approach, not taking into account the population of patients who were given life style and diet rules only or taking into account patients for whom morbidities other than hypertension could justify the use of antihypertensive drugs in the medication-based approach. The mean (confidence interval) per doctor was 33.7% (31.5–35.9) for statin indicator and 38.4% (35.4–41.4) for aspirin indicator when the target populations were identified on the basis of clinical criteria whereas they were 37.9% (36.3–39.4) and 43.8% (41.4–46.3) on the basis of treatment criteria. CONCLUSION: The two approaches yield very “similar” scores but these scores cover different realities and offer food for thought on the possible usage of these indicators in the framework of P4P programmes.
format Online
Article
Text
id pubmed-3334971
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33349712012-04-25 Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations Saint-Lary, Olivier Boisnault, Philippe Naiditch, Michel Szidon, Philippe Duhot, Didier Bourgueil, Yann Pelletier-Fleury, Nathalie PLoS One Research Article CONTEXT: From one country to another, the pay-for-performance mechanisms differ on one significant point: the identification of target populations, that is, populations which serve as a basis for calculating the indicators. The aim of this study was to compare clinical versus medication-based identification of populations of patients with diabetes and hypertension over the age of 50 (for men) or 60 (for women), and any consequences this may have on the calculation of P4P indicators. METHODS: A comparative, retrospective, observational study was carried out with clinical and prescription data from a panel of general practitioners (GPs), the Observatory of General Medicine (OMG) for the year 2007. Two indicators regarding the prescription for statins and aspirin in these populations were calculated. RESULTS: We analyzed data from 21.690 patients collected by 61 GPs via electronic medical files. Following the clinical-based approach, 2.278 patients were diabetic, 8,271 had hypertension and 1.539 had both against respectively 1.730, 8.511 and 1.304 following the medication-based approach (% agreement = 96%, kappa = 0.69). The main reasons for these differences were: forgetting to code the morbidities in the clinical approach, not taking into account the population of patients who were given life style and diet rules only or taking into account patients for whom morbidities other than hypertension could justify the use of antihypertensive drugs in the medication-based approach. The mean (confidence interval) per doctor was 33.7% (31.5–35.9) for statin indicator and 38.4% (35.4–41.4) for aspirin indicator when the target populations were identified on the basis of clinical criteria whereas they were 37.9% (36.3–39.4) and 43.8% (41.4–46.3) on the basis of treatment criteria. CONCLUSION: The two approaches yield very “similar” scores but these scores cover different realities and offer food for thought on the possible usage of these indicators in the framework of P4P programmes. Public Library of Science 2012-04-20 /pmc/articles/PMC3334971/ /pubmed/22536430 http://dx.doi.org/10.1371/journal.pone.0035721 Text en Saint-Lary et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Saint-Lary, Olivier
Boisnault, Philippe
Naiditch, Michel
Szidon, Philippe
Duhot, Didier
Bourgueil, Yann
Pelletier-Fleury, Nathalie
Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations
title Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations
title_full Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations
title_fullStr Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations
title_full_unstemmed Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations
title_short Performance Scores in General Practice: A Comparison between the Clinical versus Medication-Based Approach to Identify Target Populations
title_sort performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334971/
https://www.ncbi.nlm.nih.gov/pubmed/22536430
http://dx.doi.org/10.1371/journal.pone.0035721
work_keys_str_mv AT saintlaryolivier performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations
AT boisnaultphilippe performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations
AT naiditchmichel performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations
AT szidonphilippe performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations
AT duhotdidier performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations
AT bourgueilyann performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations
AT pelletierfleurynathalie performancescoresingeneralpracticeacomparisonbetweentheclinicalversusmedicationbasedapproachtoidentifytargetpopulations